TIANJING BIOTECHNOLOGY (SHANGHAI) CO

Tianjing Biotechnology (Shanghai) Co is develops drugs for tumor immunity and autoimmune diseases.

#SimilarOrganizations #More

TIANJING BIOTECHNOLOGY (SHANGHAI) CO

Industry:
Biotechnology Life Science

Address:
Shanghai, Shanghai, China

Country:
China

Status:
Active


Similar Organizations

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

onegene-biotechnology-logo

Onegene Biotechnology

Onegene Biotechnology develops highly potent tri- or intraspecific protein-based drugs.

More informations about "Tianjing Biotechnology (Shanghai) Co"

Tianjing Biotechnology (Shanghai) Co - Drug pipelines, Patents ...

Explore Tianjing Biotechnology (Shanghai) Co with its drug pipeline, therapeutic area, technology platform, . Explore Tianjing Biotechnology (Shanghai) Co with its drug pipeline, therapeutic โ€ฆSee details»

I-Mab Biopharma - Funding, Financials, Valuation & Investors

Mar 23, 2017 Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Tianjing Biotechnology โ€ฆSee details»

I-Mab Biopharma - Crunchbase Company Profile & Funding

Also Known As Tianzhenshi Biotechnology Company, ๅคฉๅขƒ็”Ÿ็‰ฉ , Tianjing Shengwu, ๅคฉๅขƒ็”Ÿ็‰ฉ็ง‘ๆŠ€๏ผˆไธŠๆตท๏ผ‰ๆœ‰้™ๅ…ฌๅธ; Legal Name I-Mab Biopharma (Shanghai) Co., Ltd. Stock Symbol โ€ฆSee details»

Novo Nordisk China - PharmaBoardroom

Feb 13, 2014 In 1994 Novo Nordisk decided to invest in China by setting up Novo Nordisk (Tianjin) Biotechnology Co., Ltd., which was later renamed Novo Nordisk (China) โ€ฆSee details»

General

Explore Tianjing Biotechnology (Shanghai) Co profile on Finallot for insights on its team, products, and industry - Tianjing Biotechnology (Shanghai) Co develops drugs for tumor immunity and โ€ฆSee details»

I-Mab Signs Agreement to Divest its Assets and Business โ€ฆ

Feb 7, 2024 Pursuant to the definitive agreements, the Company will transfer 100% of the outstanding equity interest in I-Mab Biopharma Co., Ltd. (โ€œI-Mab Shanghaiโ€), a wholly owned โ€ฆSee details»

Tianjing Biotechnology - Products, Competitors, Financials, โ€ฆ

Tianjing Biotechnology focuses on the development and commercialization of biopharmaceuticals. Use the CB Insights Platform to explore Tianjing Biotechnology's full profile. Tianjing โ€ฆSee details»

Tianjin XHR Biotechnology Co.,LTD - xhrpharm.com

Tianjin XHR Biotechnology Co.,LTD. was founded in 2018, focusing on global high-quality pharmaceutical excipients. The company is headquartered in Tianjin, and has set up sales and โ€ฆSee details»

Top 10 Biotech companies in China: 5 Chinese and 5 โ€ฆ

Jun 17, 2024 Company Name: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Website: www.fosunpharma.com; Location: Shanghai; Stock Exchange: Shanghai Stock Exchange (Ticker: 600196) Overview: Established in 1994, โ€ฆSee details»

I-Mab Biopharma acquires Tianjing Biotechnology (Shanghai) Co

Mar 23, 2017 Acquired Organization: Tianjing Biotechnology (Shanghai) Co Tianjing Biotechnology (Shanghai) Co is develops drugs for tumor immunity and autoimmune diseases. โ€ฆSee details»

Shanghai Tianjing Lijie Biotechnology Co., Ltd.: Drug pipelines ...

Sep 4, 2023 0 Patents (Medical) associated with Shanghai Tianjing Lijie Biotechnology Co., Ltd. Login to view more data. Pipeline. Pipeline Snapshot as of 04 Sep 2023.See details»

Shanghai Tianjing Diyi Biotechnology Co.,Ltd

Shanghai Tianjing Diyi Biotechnology Co.,Ltd ... Add๏ผš Room 1808 Zhongyi Building No.1040 Hongyi Road,Putuo District Shanghai China. Shanghai Tianjing Diyi Instrument Co.,Ltd ©2023 โ€ฆSee details»

Mission Statement, Vision, & Core Values (2024) of Shanghai โ€ฆ

Year R&D Investment (% of Revenue) New Products Launched Quality Compliance Rate (%) Customer Satisfaction Rate (%) 2021 12% 3 89% 87% 2022 14% 4 91% 88% 2023 15% 5 โ€ฆSee details»

Shanghai Tianjin Biotechnology Co., Ltd. - Drug pipelines, Patents ...

Last update 01 Nov 2024. Shanghai Tianjin Biotechnology Co., Ltd. Private Company |See details»

Top experts "team up" to explore the "Tianjin path" for the ...

Chen Yihua, sales representative of Union Biotech Co., Ltd., told reporters: "We have been developing in the south before. ... we will form an innovation highland for the transformation of โ€ฆSee details»

Conjustar - Crunchbase Company Profile & Funding

Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers โ€ฆSee details»

T&j Bio-Engineering (shanghai) Co., Ltd. - overseadia.baidu.com

Biotechnology is promoting the improvement of our quality of life, and as an advanced bioreactor system development supplier, T&J is obliged to contribute to the development of life sciences โ€ฆSee details»

Tiangong Biotechnology (Tianjin) Co., Ltd. - Drug pipelines

100 Translational Medicine associated with Tiangong Biotechnology (Tianjin) Co., Ltd. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. โ€ฆSee details»

linkstock.net © 2022. All rights reserved